Missing/wrong data?
Log in to edit
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
scientific article
Author/s
author: Eric Pujade-Lauraine, Tomasz Huzarski, Keiichi Fujiwara, Isabelle Ray-Coquard, Susana Banerjee, Nicoletta Colombo, Amit M. Oza
Work details
Publication date
July 25, 2017
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.